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Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is currently the fifth leading cause of death in
Australia, and there are marked differences in mortality trends between men and women. In this study, we have
sought to model and forecast age related changes in COPD mortality over time for men and women separately
over the period 2006-2025.
Methods: Annual COPD death rates in Australia from 1922 to 2005 for age groups (50-54, 55-59, 60-64, 65-69, 70-
74, 75-79, 80-84, 85+) were used. Functional time series models of age-specific COPD mortality rates for men and
women were used, and forecasts of mortality rates were modelled separately for men and women.
Results: Functional time series models with four basis functions were fitted to each population separately. Twenty-
year forecasts were computed, and indicated an overall decline. This decline may be slower for women than for
men. By age, we expect similar rates of decline in men over time. In contrast, for women, forecasts for the age
group 75-79 years suggest less of a decline over time compared to younger age groups.
Conclusions: By using a new method to predict age-specific trends in COPD mortality over time, this study
provides important insights into at-risk age groups for men and women separately, which has implications for
policy and program development.
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Background
Chronic Obstructive Pulmonary Disease (COPD), includ-
ing chronic bronchitis and emphysema, is currently the
fifth leading cause of death in Australia. It was responsi-
ble for 31.2 male and 16.3 female deaths per 100,000
population (age-standardized) in 2005 [1].
The major known risk factor is tobacco smoking. How-
ever, there is a substantial latent period after the uptake
of regular smoking, so that COPD typically only becomes
manifest decades later. COPD is the only major condition
for which the burden of disease (as measured at the
population level) is continuing to increase with an ageing
population, which is at a higher risk of developing COPD
[2]. This is because COPD results in a progressive
respiratory disability, a substantial impairment in the
quality of life and frequent hospital admissions. COPD is
also accompanied by substantial comorbidities, including
depression, heart disease and osteoporosis. Yearly mor-
tality time trends which are collected by the Australian
Bureau of Statistics provide a sound basis for modelling
the occurrence of COPD over the twentieth century and
for predicting the likely situation over the next 20 years.
A model which predicts future age-specific COPD mor-
tality rates separately for men and women should also
enable policy-makers to extrapolate the health care costs
associated with treatment, and to calculate the probable
economic benefit of policies which effectively eliminate
smoking and control other risk factors.
In this study, we use functional data analysis (FDA) tech-
niques to model age-specific time trends of COPD mortal-
ity rates for men and women in Australia, and to estimate
future mortality rates over the next two decades. The use
of models which also incorporate functional data analysis
for forecasting mortality is relatively new. Hyndman and
Ullah [3] proposed forecasting age-specific mortality rates
which are observed over time. These forecasting models
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rather than using only the most recently available data.
These models are an alternative to the age-period-cohort
models which are commonly used to model and predict
future mortality trends over time.
In this study we seek to: a) model age related changes
in COPD mortality time trends separately for men and
women using functional data analysis, and b) predict
future age related changes in COPD mortality rates
separately for men and women.
Methods
Data
The annual COPD death rates (1922-2005) for the age
groups (50-54, 55-59, 60-64, 65-69, 70- 74, 75-79, 80-84,
85+) were obtained from the General Record of Inci-
dence of Mortality (GRIM) books maintained by the Aus-
tralian Institute of Health and Welfare [4]. These COPD
mortality rates are defined as the number of deaths in a
particular age group during the year, divided by the cor-
responding mid-year population. The rate is expressed
per 100,000 people. Data for COPD (ICD10 J41-J44) are
available from 1922 to 2005. All deaths have been
mapped to ICD10 codes, in accordance with Taylor [5],
and, more recently, the ICD (International Classification
of Disease) 9-ICD10 mapping tables released by the
World Health Organization.
Functional data analysis models
In this study, we use the annual COPD mortality rates as a
f u n c t i o no fa g e( t a k e nt ob et h em i d p o i n to ft h ea g e
groups). We plot the age and mortality for each year, and
define these as mortality-age curves. We take the log of
COPD mortality and use functional data analysis (FDA)
techniques [6] to model these curves collectively as a func-
tional time series. We first smooth the data for each year
using a nonparametric smoothing method, in order to
estimate these functions. As the mortality rates are func-
t i o n so fa g e ,w ea s s u m et h a tt h ee s t i m a b l ef u n c t i o n s
increase monotonically with age (where age is at least
50 years). To capture these trends, we use constrained
penalized regression splines [7,8]. We define these smooth
curves as our functional observations, and fit FDA models,
as proposed by Hyndman and Ullah [3], to estimate the
functions which represent the age-mortality relationship.
Each curve is expressed as a linear function of nonpara-
metric basis functions, defined using a principal compo-
nent decomposition; in practice, we find that the use of
about four or five basis functions is usually sufficient to
capture the variations in the data. The basis functions do
not vary with time, but the associated coefficients (the
principal component scores) form time series which can
be forecast. This separation of age effects (the basis func-
tions) and time effects (the coefficients) enables the age-
specific mortality rates to be forecast into the future while
taking the correlations between ages and across time into
account.
Forecasting
For forecasting each coefficient in our FDA model, and
for constructing prediction intervals, we use exponential
smoothing state space models [9] via the automatic
model-selection algorithm of Hyndman et al. [10]. The
specific univariate forecasting method is not important,
provided that it can handle a variety of time-varying
trends.
We use the Mean Integrated Squared Forecasting
Error to evaluate the accuracy of the estimated forecasts
of future mortalities [3]. This is proportional to the
average squared distance between the actual mortality
curves and the forecast mortality curves. All statistical
analyses were performed in R version 2.10.1.
Results
Figure 1 shows the Australian COPD mortality rates for
five-year age groups between the ages of 50 and 85+
years over the period 1922-2005. The top panel shows
the mortality rates for men and the bottom panel shows
the mortality rates for women. The COPD mortality
trends for men first began to rise during the 1950s, with
the maximum mortality rates for the age group 80-84
being in 1980. They were at their peak during the three
decades from the beginning of the 1970s to the end of
the 1990s. The COPD mortality trends for women began
to increase in 1960 and then peaked in the late 1980s to
early 1990s.
In the figure, the rates are simply treated as a collection
of discrete observations, without any regard to the under-
lying probabilistic models. Important features of this time
plot are the nonlinear pattern and the evidence of a non-
constant variance. The observational error is also clear
(as the lines are not smooth), as is the increasing variance
for higher ages in the mortality data, particularly in the
early part of the century. Clearly, any forecasts of these
data will need to be able to model the complex dynamic
behavior observed.
Model diagnostics suggest that a set of k = 4 basis func-
tions is adequate for both the male and female mortality
rates. These four basis functions for men explain 89.9%,
8.3%, 1.2% and 0.4% of the total variation, respectively,
and the figures for women are 80.6%, 13.9%, 4.3% and
0.8%. Figure 2(a) and 2(b) shows twenty-year forecasts of
the coefficients associated with the first two basis func-
tions, along with 80% prediction intervals, for men and
women respectively. Trends in COPD mortality rates
among men have been declining since 1970 and the rates
are expected to continue to decline for the next 20 years.
Likewise, the trends in COPD mortality rates among
women are expected to decline, but at a lower rate than
that of men. The wide prediction intervals in the mortality
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uncertainty in the strength of this trend.
Figure 3 displays the 20-year forecasts by age for men
(top panel) and women (bottom panel). For men, the fore-
casts for the next 20 years suggest a decline in the rate of
change of mortality for all age groups, ranging from a
decline of 37.1% among those 50 to 54 years of age to a
decline of 47.8% among those 75 to 79 years of age. We
expect slower rates of decline in COPD mortality for
women. For example, we expect the rate of decline to be
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Figure 1 Age-specific COPD mortality rates in Australia for men (top) and women (bottom) separately, 1922-2005.
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Page 3 of 932.0% among women from 50 to 54 years of age over the
next 20 years, and 21.7% among those 75 to 79 years of age.
We conducted a sensitivity analysis excluding data
before 1960 and refitted the models for the period 1960-
2005. For the sensitivity analysis the scale of coefficients
were changed from centered on zero to recentered for
both male and female The estimated set of k = 4 basis
functions did not change. In addition, there was very
Figure 2 20 year forecasts of the first two coefficients using state space exponential smoothing models with additive errors and a
damped trend for (a) men and (b) women. The shaded region represents 80% prediction intervals.
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Figure 3 Forecasts of age-specific COPD mortality rates for the years 2006-2025, for men (top panel) and women (bottom panel).
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Page 5 of 9little difference in the estimated 20 year forecasts by age
for men and women compared to 20 year forecasts from
the original models [See Figure 4].
Discussion
To the best of our knowledge, this is the first study to
i n c o r p o r a t et h ee f f e c t so fa g e - s p e c i f i ct i m et r e n d so n
COPD mortality separately for men and women when
estimating future trends in COPD mortality. Our find-
ings suggest that overall COPD mortality trends will
continue to decline, but that this decline will be later
for women than for men.
As our focus was on comparing the COPD mortality
rates of men and women, we did not compare our
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Figure 4 Forecasts of age-specific COPD mortality rates for the years 2006-2025 excluding data before 1960, for men (top panel) and
women (bottom panel).
Erbas et al. BMC Medical Research Methodology 2012, 12:17
http://www.biomedcentral.com/1471-2288/12/17
Page 6 of 9overall COPD mortality trends with those found in
other studies directly. However, our findings on the
decline of COPD mortality rates among men are in
agreement with studies in many other countries. Using
an age adjusted trend analysis, M.J. Goldacre and collea-
gues [11] demonstrated an overall decline in COPD
mortality for men in England over the period 1979-
1 9 9 8 .W h e ns t r a t i f i e db ya g e ,t h e ya l s of o u n dad e c l i n e
for all age groups. An earlier study of COPD mortality
trends in Canada for the period 1951-1995 [12] reported
a decline in the overall COPD mortality for men, with a
decline in the 65-74 year age group and an increase
among men over 75 years of age. In the United States
(USA), COPD mortality rates increased from 1968 to
mid 1980s, [13] stabilized, and then declined after 2000
[14]. Similarly, the mortality trends for men in France
began to decline steadily after 1985, and further declined
between 2000 and 2002 [15].
Our findings on increasing COPD mortality trends for
women pre-1997 parallel the patterns observed in studies
in other industrialized countries. However, our findings on
the decline over recent years are not in agreement with
these studies, as recent data are not yet available for com-
parison. In the United Kingdom (UK), rates for women
continued to increase between 1978 and 1998, with the
greatest increase being in women over 65 years of age.
This finding was consistent across the different combina-
tions used to code the underlying cause of death [11]. We
do not have more recent UK data for a comparison of
trends beyond 1998. Similarly, COPD mortality rates for
women in Canada continued to increase from the late
1950s to 1995, with an increase in age-specific mortality
rates in women aged 65 years and over [12]. More recent
data from the United States suggest that COPD mortality
rates among women tripled between 1980 and 2000, and
in 2000 were higher than the rates in men [14]. Our find-
ings are in agreement with a study from France (where
recent data were available) which found that female mor-
tality rates increased slightly between 1979 and 1999 and
declined thereafter [15].
The difference in mortality trends between men and
women may be explained by a number of factors. The
main causal factor is tobacco exposure. COPD mortality
trends in men first began to rise during the 1950s, with
the maximum death rates for the age group 80-84 in 1980.
The trends in COPD mortality rates among men mirrored
the pattern of the uptake of smoking 50 years earlier. By
1945, almost 72% of men were smokers. Smoking rates
among men then fell sharply during the 1950s and early
1960s when concerns about effects on health were first
raised [16,17], but, as a result of the aggressive marketing
of tobacco products to younger smokers in the 1960s and
1970s, subsequently remained stable until the early 1980s
and the advent of organized Quit campaigns.
Similarly, the patterns of COPD mortality trends
among women have reflected the patterns of smoking
uptake among women. In the years leading up to and
during World War II, the advent of movies depicting gla-
morous images of women smoking, the entry of women
into the workforce, and the development of cigarette
brands which were attractive to women resulted in wide-
spread uptake, with more than one in every four women
reported as smoking by 1945 [18].
While many women also quit in response to the health
concerns raised in the later 1950s and early 1960s, the
effects of this were offset by increased uptake by women
who were born in the 1950s and 1960s, corresponding to
aggressive marketing by the tobacco companies, and the
increased economic and social freedom of women since
that time. Smoking rates therefore barely changed until
the late 1980s, but have been declining steadily since
1998 [19].
In addition, these effects may be prolonged by the action
of other risk factors such as genetics, indoor and outdoor
environment, and lifestyle [20,21]. Other factors include
the possible biological and physiological differences
between men and women [22]. Women seem to be less
likely to be diagnosed with COPD (even with severe dis-
ability), and more likely to be misdiagnosed with asthma
than men. Chapman and colleagues [23] found that physi-
cians were less likely to diagnose COPD in women (49%)
than in men (64.6%), where both presented with hypothe-
tical cases of cough and dyspnea. Women may also differ
from men in their response to treatment and disease man-
agement [24]. All of these factors subsequently diminish
the quality of life with a longer survival time.
Comprehensive tobacco control policies and the decline
in tobacco consumption since the early 1970s may explain
a considerable component of the declining trend of COPD
mortality in women in Australia. As is discussed above,
this trend has not been observed in many other countries
with a similar population-mix. This may reflect the earlier
decline in tobacco consumption in Australia, compared to
countries such as the UK and the US; and the considerable
success of Australia’s QUIT Campaign, compared to
smoking cessation strategies in other countries.
There are few published forecasts of age-specific COPD
mortality. Two studies from the Netherlands [20,25] devel-
oped a dynamic multistate life table model for modelling
the prevalence, mortality and health care costs of COPD.
Their simulations suggested an increase in COPD-related
deaths for both men and women by 2025. These increases
became more pronounced in women than men when esti-
mates of smoking prevalence were factored into the
model. It is difficult to compare our forecasts with the
forecasts from this study because of the differences in
modeling approaches and assumptions. For example, these
studies assumed constant age- and sex-specific mortality
Erbas et al. BMC Medical Research Methodology 2012, 12:17
http://www.biomedcentral.com/1471-2288/12/17
Page 7 of 9rates for each of disease severity and smoking class. In
contrast, our modeling approach produces forecasts based
on the entire functional form of the age-mortality curve
over time (although they do not take the intervention
effects of smoking behavior into account).
The modeling and forecasting approach adopted in this
study has a number of strengths. It has the ability to
model the functional form of age-related changes in mor-
tality rates over time and make predictions for specific age
groups. This enables us to understand the different pat-
terns of disease progression for men and women in
younger, middle and older age groups. It provides impor-
tant insights into the natural history of COPD, which has
implications for policy and program development for at-
risk age groups.
A second major strength of our approach is the
improved modeling of sudden directional changes or
jumps in the trends of an outcome. An earlier study of
COPD deaths in Australia between 1993 and 2003, and
one which generated a considerable amount of debate,
modeled the data using linear regression with autocorre-
lated errors, but failed to capture the sudden change in
COPD mortality rates around 1997 [26]. While it is impor-
tant to understand the reason for this change in the dis-
ease pattern, it is equally important for the models and the
predictions which they generate to allow for this structural
change. The failure to do this is a common phenomenon
in trend studies of disease outcomes such as prevalence,
incidence and mortality.
Some limitations should be considered when interpret-
ing the results. Our models and the subsequent forecasts
do not take into account trends in tobacco consumption,
which remains the most important causative factor for
COPD in Australia, or the fact that there is a considerable
“lag time” between consumption and COPD mortality.
The models also fail to take into account intervention
effects such as the commencement of smoking cessation
programs. There are also well-recognized limitations of
mortality data which we do not incorporate into the mod-
els. The ascertainment of COPD is often incomplete, as
the diagnosis may not have been made during life [27], or
may simply have been overlooked in completing the death
certificate. COPD is listed as the underlying cause of death
only a minority of the time [28]. There have also been
changes in the coding of respiratory deaths in the ICD
between the third revision in 1922 and the tenth in 1999.
These changes confound any interpretation of long-term
trends. At present our modeling techniques do not allow
for birth-cohort trends, although our diagnostic tests
revealed little evidence of cohort trends, with a negligible
impact on the estimated basis functions and forecasts.
The national guidelines for COPD management
emphasize the cessation of smoking as the only interven-
tion proven to slow the decline in lung function [29,30].
From the graphs it seems that mortality is declining at a
slower rate for older women. This is an important finding
because this is probably the result of a cumulative expo-
sure to smoking, passive smoking and other lifestyle
variables.
Conclusions
In summary, this is the first study to model and forecast
age specific COPD mortality trends in Australia for men
and women separately. The predictions suggest widen-
ing disparities between men and women in future, parti-
cularly among older women. These data provide further
insights into age related changes in COPD mortality.
Although cessation programs target all smokers - irre-
spective of age, these data can be used to inform public
health prevention policy about possible age groups that
may require additional interventions.
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